The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome

Pathology Research and Practice

Volumn 205, Issue 1, 2009, Pages 35-41

  Teksam, Ozlem ^a   Kale, Gulsev ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antenatal steroid treatment; Lung histopathology; Preterm infant; Respiratory distress syndrome; Surfactant treatment

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; SURFACTANT;

ANTIOXIDANT ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; AUTOPSY; BAROTRAUMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE MEMBRANE DISEASE; INCIDENCE; LUNG EMPHYSEMA; LUNG HEMORRHAGE; LUNG PARENCHYMA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN TOXICITY; PNEUMONIA; PREMATURITY; PRENATAL PERIOD;

ADRENAL CORTEX HORMONES; AUTOPSY; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; HEMORRHAGE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PNEUMONIA; PULMONARY ATELECTASIS; PULMONARY EMPHYSEMA; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY SYSTEM AGENTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 57249095811     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.08.004     Document Type: Article

References (23)

1. Agustines L.A., Lin Y.G., Rumney P.J., et al. Outcomes of extremely low birth weight infants between 500 and 750 g. Am. J. Obstet. Gynecol. 182 (2000) 1113-1116
2. Angus D.C., Linde-Zwirble W.T., Clermont G., et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am. J. Respir. Crit. Care. Med. 164 (2001) 1154-1160
3. Bhakoo O.N., Narang A., Karthikeyan G., et al. Spectrum of respiratory distress in very low birth weight neonates. Indian J. Pediatr. 67 (2000) 803-804
4. Bhutani V.K., Abbasi S., Long W.A., and Gerdes J.S. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J. Pediatr. 120 (1992) 18-24
5. Cole V.A., Normand I.C.S., Reynolds E.O.R., and Rivers R.P.A. Pathogenesis of hemorrhagic pulmonary edema and massive pulmonary hemorrhage in the newborn. Pediatrics 51 (1973) 175-187
6. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst. Rev. 2 (2000)
7. deMello D.E., Noguchi A., and Gunkel H. Absence of survanta-related lung histologic changes at autopsy in infants with hyaline membrane disease. Pediatr. Res. 33 (1993) 1915 (Abst.)
8. Kari M.A., Hallman M., Eronen M., Teramo K., et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 93 (1994) 730-736
9. Liechty E.A., Donovan E., Purohit D., Gilholly J., Feldman B., et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 88 (1991) 19-28
10. Long W., Corbet A., Allen A., et al. Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. J. Pediatr. 120 suppl. (1992) 45-48
11. Pappin A., Shenker N., Hack M., and Redline R.W. Extensive intraalveolar pulmonary hemorrhage in infants dying after surfactant therapy. J. Pediatr. 124 (1994) 621-626
12. Pejaver R.K., Al Hitzi I., and Aldussari S. Surfactant replacement therapy: economic impact. Indian J. Pediatr. 68 (2001) 501-505
13. Pinar H., Makarova N., Rubin L.P., and Singer D.B. Pathology of the lung in surfactant-treated neonates. Pediatr. Pathol. 14 (1994) 627-636
14. Premarick A.K., Holtzman R.B., and Merritt T.A. Surfactant replacement therapy for pulmonary diseases. Update Neonatol. 40 (1993) 913-936
15. Raju T.N.K., and Langenberger P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J. Pediatr. 123 (1993) 603-610
16. Raju T.N.K., Vidyasagar D., Bhat R., et al. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1 (1987) 651-656
17. Rubaltelli F.F., Bonafe L., Tangucci M., et al. Epidemiology of neonatal acute respiratory disorders: a multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery. Italian group of neonatal pneumology. Biol. Neonate 74 (1998) 7-15
18. Shima Y., Takemura T., Akamatsu H., Kawakami T., and Yoda H. Clinicopathological analysis of premature infants treated with artificial surfactant. J. Nippon Med. Sch. 67 (2000) 330-334
19. Silver R.K., Vyskocil C., Solomon S.L., Ragin A., et al. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks gestation. Obstet. Gynecol. 87 (1996) 683-691
20. Stevenson D., Walther F., Long W., et al. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500-699 g. J. Pediatr. 120 suppl. (1992) 3-12
21. Thornfeldt R.E., Franklin R.W., Pickering N.A., Thornfeldt C.R., and Amell G. The effect of glucocorticoids on the maturation of premature lung membranes: preventing the respiratory distress syndrome by glucocorticoids. Am. J. Obstet. Gynecol. 131 (1978) 143-148
22. Thornton C.M., Halliday H.L., and O'Hara M.D. Surfactant replacement therapy in preterm neonates: a comparison of postmortem pulmonary histology in treated and untreated infants. Pediatr. Pathol. 14 (1994) 945-953
23. Toti P., Buonocore G., Rinaldi G., Catella A.M., and Bracci R. Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study. Biol. Neonate 70 (1996) 21-28